ADMAADMA Biologics, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $9.25 (+0.65% today)

Market Cap: $2.19B

P/E (TTM): 14.90

Forward P/E (FY1): 9.70

EPS Growth: 33.5%

Relative Strength (RS%): 59

-64.0% from 52-week high

Back to Scanner

ADMA

NASDAQRS 59Score 39

ADMA Biologics, Inc.

HealthcareBiotechnology$2.19B2 setups passing
$9.25
+0.7% ($0.06)
-64.0% from 52W High
P/E (TTM)
14.90
Fwd P/E
9.70
PEG
0.16
Analyst Upside
EPS Growth
33.5%
Gross Margin
57.4%
ROE
35.0%
D/E
0.17
Div Yield
0.0%
Avg Volume
6.1M

Price Chart

Key Levels

SMA 200
$16.60
SMA 50
$14.96
Price
$9.25
52W High
$25.69

Setup Radar

2/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst